FDA Approved: METHADOSE DISPERSIBLE — Supplemental Application (SpecGx LLC)

View source ↗

Summary

FDA approved a supplemental application for METHADOSE DISPERSIBLE (methadone hydrochloride) from SpecGx LLC under ANDA 074184.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Pain

Drugs mentioned

• METHADOSE DISPERSIBLE (METHADONE HYDROCHLORIDE)

Snippet

SUPPL AP for METHADOSE DISPERSIBLE (METHADONE HYDROCHLORIDE)